{"id":44323,"date":"2022-05-25T12:01:22","date_gmt":"2022-05-25T10:01:22","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/spectrum-solutions-receives-irb-approval-for-saliva-based-multi-omic-discovery-detection-and-diagnostic-innovation\/"},"modified":"2022-05-25T12:01:22","modified_gmt":"2022-05-25T10:01:22","slug":"spectrum-solutions-receives-irb-approval-for-saliva-based-multi-omic-discovery-detection-and-diagnostic-innovation","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/spectrum-solutions-receives-irb-approval-for-saliva-based-multi-omic-discovery-detection-and-diagnostic-innovation\/","title":{"rendered":"Spectrum Solutions Receives IRB Approval for Saliva-Based Multi-Omic Discovery, Detection and Diagnostic Innovation"},"content":{"rendered":"
\n

SALT LAKE CITY–(BUSINESS WIRE)–Spectrum Solutions<\/a>, LLC today announced its medical science division has received independent institutional review board (IRB) approval from Sterling IRB<\/a> to drive saliva-based multi-omic discovery, detection, and diagnostic innovation. This broad reaching IRB clearance highlights a focus on noninvasive molecular diagnostic and antigen-based multiplex RT-PCR testing using human saliva collected, stabilized, and amplified with the Spectrum saliva self-collection system under the direction of principal investigator and Spectrum\u2019s Chief Science Officer, David J Vigerust, PhD.\n<\/p>\n

<\/a><\/p>\n

\nAt the start of the pandemic, Spectrum Solutions was the first to push the boundaries of discovery and expand the nation\u2019s diagnostic awareness to a safer option using saliva. As a result, Spectrum\u2019s noninvasive saliva self-collection innovation was the first to receive FDA Emergency Use Authorization (EUA) for saliva-based COVID-19 testing. The vast benefits of this advance in clinical diagnostic healthcare using saliva continue to reach across the multiverse of omics and ologies impacting patient outcomes worldwide.\n<\/p>\n

\n\u201cWe are excited to see testing service providers, medical facilities and laboratories around the globe embracing and favoring saliva-based testing using Spectrum\u2019s innovation for its unparalleled ease-of-use and safety,\u201d said Rohit Gupta, Chief Medical Officer at Spectrum Solutions.\n<\/p>\n

\nAmong others, this study highlights two key elements to advancing, modernizing, and safely managing remote care. First, the early detection and in-device neutralization of multiple pathogens in a single saliva test and second, the importance of consistent, robust post-collection sample stability at ambient temperatures offering stress-free storage and extended transport solutions.\n<\/p>\n

\nABOUT SPECTRUM SOLUTIONS<\/b>\n<\/p>\n

\nHeadquartered in Salt Lake City, Utah, Spectrum Solutions is a life science company using its focused industry expertise to drive noninvasive saliva molecular diagnostic and screening innovation. Our pioneering research, products, engineering, and development-to-delivery commercialization capabilities are setting new standards of modernized care for patients, providers, and laboratories in the testing, managing, and treatment of disease. We believe when you bridge the gap between science and real medical solutions you deliver innovation with the practical power to impact and change outcomes. For more information, please visit spectrumsolution.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nTim Rush
\n
Springboard5 for Spectrum Solutions
\n
801-208-1100
\n
tim.rush@springboard5.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

SALT LAKE CITY–(BUSINESS WIRE)–Spectrum Solutions, LLC today announced its medical science division has received independent institutional review board (IRB) approval from Sterling IRB to drive saliva-based multi-omic discovery, detection, and diagnostic innovation. This broad reaching IRB clearance highlights a focus on noninvasive molecular diagnostic and antigen-based multiplex RT-PCR testing using human saliva collected, stabilized, and … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-44323","6":"format-standard","7":"category-industry"},"yoast_head":"\nSpectrum Solutions Receives IRB Approval for Saliva-Based Multi-Omic Discovery, Detection and Diagnostic Innovation - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/spectrum-solutions-receives-irb-approval-for-saliva-based-multi-omic-discovery-detection-and-diagnostic-innovation\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Spectrum Solutions Receives IRB Approval for Saliva-Based Multi-Omic Discovery, Detection and Diagnostic Innovation - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"SALT LAKE CITY–(BUSINESS WIRE)–Spectrum Solutions, LLC today announced its medical science division has received independent institutional review board (IRB) approval from Sterling IRB to drive saliva-based multi-omic discovery, detection, and diagnostic innovation. This broad reaching IRB clearance highlights a focus on noninvasive molecular diagnostic and antigen-based multiplex RT-PCR testing using human saliva collected, stabilized, and ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/spectrum-solutions-receives-irb-approval-for-saliva-based-multi-omic-discovery-detection-and-diagnostic-innovation\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-05-25T10:01:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220525005385\/en\/1466841\/21\/Spectrum_Solutions_Logo-Vector-01_%28002%29.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/spectrum-solutions-receives-irb-approval-for-saliva-based-multi-omic-discovery-detection-and-diagnostic-innovation\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/spectrum-solutions-receives-irb-approval-for-saliva-based-multi-omic-discovery-detection-and-diagnostic-innovation\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Spectrum Solutions Receives IRB Approval for Saliva-Based Multi-Omic Discovery, Detection and Diagnostic Innovation\",\"datePublished\":\"2022-05-25T10:01:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/spectrum-solutions-receives-irb-approval-for-saliva-based-multi-omic-discovery-detection-and-diagnostic-innovation\\\/\"},\"wordCount\":366,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/spectrum-solutions-receives-irb-approval-for-saliva-based-multi-omic-discovery-detection-and-diagnostic-innovation\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220525005385\\\/en\\\/1466841\\\/21\\\/Spectrum_Solutions_Logo-Vector-01_%28002%29.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/spectrum-solutions-receives-irb-approval-for-saliva-based-multi-omic-discovery-detection-and-diagnostic-innovation\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/spectrum-solutions-receives-irb-approval-for-saliva-based-multi-omic-discovery-detection-and-diagnostic-innovation\\\/\",\"name\":\"Spectrum Solutions Receives IRB Approval for Saliva-Based Multi-Omic Discovery, Detection and Diagnostic Innovation - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/spectrum-solutions-receives-irb-approval-for-saliva-based-multi-omic-discovery-detection-and-diagnostic-innovation\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/spectrum-solutions-receives-irb-approval-for-saliva-based-multi-omic-discovery-detection-and-diagnostic-innovation\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220525005385\\\/en\\\/1466841\\\/21\\\/Spectrum_Solutions_Logo-Vector-01_%28002%29.jpg\",\"datePublished\":\"2022-05-25T10:01:22+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/spectrum-solutions-receives-irb-approval-for-saliva-based-multi-omic-discovery-detection-and-diagnostic-innovation\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/spectrum-solutions-receives-irb-approval-for-saliva-based-multi-omic-discovery-detection-and-diagnostic-innovation\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/spectrum-solutions-receives-irb-approval-for-saliva-based-multi-omic-discovery-detection-and-diagnostic-innovation\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220525005385\\\/en\\\/1466841\\\/21\\\/Spectrum_Solutions_Logo-Vector-01_%28002%29.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220525005385\\\/en\\\/1466841\\\/21\\\/Spectrum_Solutions_Logo-Vector-01_%28002%29.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/spectrum-solutions-receives-irb-approval-for-saliva-based-multi-omic-discovery-detection-and-diagnostic-innovation\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Spectrum Solutions Receives IRB Approval for Saliva-Based Multi-Omic Discovery, Detection and Diagnostic Innovation\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Spectrum Solutions Receives IRB Approval for Saliva-Based Multi-Omic Discovery, Detection and Diagnostic Innovation - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/spectrum-solutions-receives-irb-approval-for-saliva-based-multi-omic-discovery-detection-and-diagnostic-innovation\/","og_locale":"en_US","og_type":"article","og_title":"Spectrum Solutions Receives IRB Approval for Saliva-Based Multi-Omic Discovery, Detection and Diagnostic Innovation - Pharma Trend","og_description":"SALT LAKE CITY–(BUSINESS WIRE)–Spectrum Solutions, LLC today announced its medical science division has received independent institutional review board (IRB) approval from Sterling IRB to drive saliva-based multi-omic discovery, detection, and diagnostic innovation. This broad reaching IRB clearance highlights a focus on noninvasive molecular diagnostic and antigen-based multiplex RT-PCR testing using human saliva collected, stabilized, and ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/spectrum-solutions-receives-irb-approval-for-saliva-based-multi-omic-discovery-detection-and-diagnostic-innovation\/","og_site_name":"Pharma Trend","article_published_time":"2022-05-25T10:01:22+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220525005385\/en\/1466841\/21\/Spectrum_Solutions_Logo-Vector-01_%28002%29.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/spectrum-solutions-receives-irb-approval-for-saliva-based-multi-omic-discovery-detection-and-diagnostic-innovation\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/spectrum-solutions-receives-irb-approval-for-saliva-based-multi-omic-discovery-detection-and-diagnostic-innovation\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Spectrum Solutions Receives IRB Approval for Saliva-Based Multi-Omic Discovery, Detection and Diagnostic Innovation","datePublished":"2022-05-25T10:01:22+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/spectrum-solutions-receives-irb-approval-for-saliva-based-multi-omic-discovery-detection-and-diagnostic-innovation\/"},"wordCount":366,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/spectrum-solutions-receives-irb-approval-for-saliva-based-multi-omic-discovery-detection-and-diagnostic-innovation\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220525005385\/en\/1466841\/21\/Spectrum_Solutions_Logo-Vector-01_%28002%29.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/spectrum-solutions-receives-irb-approval-for-saliva-based-multi-omic-discovery-detection-and-diagnostic-innovation\/","url":"https:\/\/pharma-trend.com\/en\/spectrum-solutions-receives-irb-approval-for-saliva-based-multi-omic-discovery-detection-and-diagnostic-innovation\/","name":"Spectrum Solutions Receives IRB Approval for Saliva-Based Multi-Omic Discovery, Detection and Diagnostic Innovation - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/spectrum-solutions-receives-irb-approval-for-saliva-based-multi-omic-discovery-detection-and-diagnostic-innovation\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/spectrum-solutions-receives-irb-approval-for-saliva-based-multi-omic-discovery-detection-and-diagnostic-innovation\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220525005385\/en\/1466841\/21\/Spectrum_Solutions_Logo-Vector-01_%28002%29.jpg","datePublished":"2022-05-25T10:01:22+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/spectrum-solutions-receives-irb-approval-for-saliva-based-multi-omic-discovery-detection-and-diagnostic-innovation\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/spectrum-solutions-receives-irb-approval-for-saliva-based-multi-omic-discovery-detection-and-diagnostic-innovation\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/spectrum-solutions-receives-irb-approval-for-saliva-based-multi-omic-discovery-detection-and-diagnostic-innovation\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220525005385\/en\/1466841\/21\/Spectrum_Solutions_Logo-Vector-01_%28002%29.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220525005385\/en\/1466841\/21\/Spectrum_Solutions_Logo-Vector-01_%28002%29.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/spectrum-solutions-receives-irb-approval-for-saliva-based-multi-omic-discovery-detection-and-diagnostic-innovation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Spectrum Solutions Receives IRB Approval for Saliva-Based Multi-Omic Discovery, Detection and Diagnostic Innovation"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44323","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=44323"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44323\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=44323"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=44323"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=44323"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}